Pages that link to "Q28279108"

The following pages link to Agomelatine in the treatment of seasonal affective disorder (Q28279108):

Displaying 41 items.

• A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation (Q22305782) (← links)
• Melatonin and agomelatine for preventing seasonal affective disorder (Q24187803) (← links)
• Melatonin and agomelatine for preventing seasonal affective disorder (Q24194188) (← links)
• Agomelatine: The evidence for its place in the treatment of depression (Q24617019) (← links)
• Seasonal affective disorder, winter type: current insights and treatment options (Q28074004) (← links)
• Efficacy of agomelatine in major depressive disorder: meta-analysis and appraisal (Q28246147) (← links)
• Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression (Q28651498) (← links)
• Agomelatine in unipolar depression in clinical practice: a retrospective chart review (Q28686885) (← links)
• Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults (Q28764080) (← links)
• 5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior (Q30460367) (← links)
• 5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise (Q30462731) (← links)
• Prevention of seasonal affective disorder in daily clinical practice: results of a survey in German-speaking countries (Q33892063) (← links)
• An overview of seasonal affective disorder and its treatment options (Q34090987) (← links)
• Agomelatine, the first melatonergic antidepressant: discovery, characterization and development (Q34122643) (← links)
• A Benefit-Risk Assessment of Agomelatine in the Treatment of Major Depression (Q34207131) (← links)
• Bupropion for the treatment of seasonal affective disorder. (Q34346558) (← links)
• Agomelatine treatment of major depressive disorder (Q34600886) (← links)
• Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression (Q34632470) (← links)
• Clinical classification in mental health at the cross-roads: which direction next? (Q34721893) (← links)
• We are in the dark here: induction of depression- and anxiety-like behaviours in the diurnal fat sand rat, by short daylight or melatonin injections. (Q34796697) (← links)
• Agomelatine: a novel antidepressant (Q35628386) (← links)
• Long-term and preventative treatment for seasonal affective disorder (Q36967190) (← links)
• The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives (Q37210115) (← links)
• Agomelatine, a melatonin agonist with antidepressant properties (Q37598264) (← links)
• Vitamin D, light and mental health (Q37783690) (← links)
• Focus on agomelatine (Q37832732) (← links)
• Melatonin Receptor Agonists: New Options for Insomnia and Depression Treatment (Q37873581) (← links)
• Agomelatine for the treatment of major depressive disorder (Q37931969) (← links)
• Role of melatonin in mood disorders and the antidepressant effects of agomelatine (Q38033191) (← links)
• Agomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical review (Q38093228) (← links)
• Agomelatine in depression (Q38137187) (← links)
• Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients (Q38876395) (← links)
• Seasonal Affective Disorder (SAD): Role of Lamotrigine Augmentation to Anti-Depressant Medication in Winter Depression (Q40214930) (← links)
• Report of two double-blind randomized placebo-controlled pilot studies of a carbohydrate-rich nutrient mixture for treatment of seasonal affective disorder (SAD). (Q43273550) (← links)
• Sunrise-related headache: case report. (Q45994586) (← links)
• Chronic agomelatine treatment corrects the abnormalities in the circadian rhythm of motor activity and sleep/wake cycle induced by prenatal restraint stress in adult rats. (Q48260016) (← links)
• Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms (Q51795388) (← links)
• Depression: chronophysiology and chronotherapy (Q56506284) (← links)
• Therapeutic potential of melatonin agonists (Q58425005) (← links)
• Implementing prevention of seasonal affective disorder from patients' and physicians' perspectives - a qualitative study (Q59808481) (← links)
• Molecular basis for the association between depression and circadian rhythm (Q64090510) (← links)